UC

University Challenge Fund

Europe, Belfast, United Kingdom, Belfast

Description

University Challenge Fund is an equity investment firm that invests in startups and seed stage companies.

Investor Profile

University Challenge Fund has made 7 investments, with 0 in the past 12 months and 29% as lead.

Stage Focus

  • Seed (57%)
  • Series Unknown (29%)
  • Series A (14%)

Country Focus

  • United Kingdom (86%)
  • United States (14%)

Industry Focus

  • Biotechnology
  • Manufacturing
  • Pharmaceutical
  • Health Care
  • Clinical Trials
  • Health Diagnostics
  • Life Science
  • Product Research
  • Sports
  • Content
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does University Challenge Fund frequently co-invest with?

Clarendon Fund Managers
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 1
Crescent Capital
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
QUBIS
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2
Invest Northern Ireland
Europe, Belfast, United Kingdom, Belfast
Co-Investments: 2

What are some of recent deals done by University Challenge Fund?

Fusion Antibodies

Belfast, Belfast, United Kingdom

Fusion Antibodies specializes in producing humanized monoclonal antibodies and antibody engineering projects.

BiotechnologyClinical TrialsHealth DiagnosticsManufacturingPharmaceutical
Series UnknownJul 26, 2007
Amount Raised: $2,500,000
Avalon Instruments

Belfast, Belfast, United Kingdom

Avalon Instruments is a developer, manufacturer and seller of scientific analytical instrumentation.

Life ScienceManufacturing
Series UnknownJun 1, 2005
Sports Dynamics Ltd.

Loughborough, Leicestershire, United Kingdom

Sports Dynamics Ltd. engages in the design and development of ball launch measurement systems.

Sports
SeedJan 1, 2004
Amount Raised: $446,717
ReOx Ltd

Oxford, Oxfordshire, United Kingdom

ReOx Ltd engages in research and development of drugs for treatments of disease by controlling the activity of hypoxia inducible factor.

Health CarePharmaceuticalProduct Research
SeedAug 30, 2003
Amount Raised: $3,152,973
RioTech Pharmaceuticals

London, England, United Kingdom

RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it.

BiotechnologyHealth Care
SeedAug 1, 2003
Amount Raised: $401,476
DanioLabs

Cambridge, Cambridgeshire, United Kingdom

DanioLabs is a private UK drug discovery company.

BiotechnologyTherapeutics
SeedJul 10, 2002
Amount Raised: $1,315,287
Hidden Footprints

Reston, Virginia, United States

Hidden Footprints is a developer of digital rights
management technologies.

Content
Series AJun 28, 2001